Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

healthcare

  • Home
  •  
  • healthcare



  • Most Read
  • Latest Comments
  • National Institutes of Health engage Imricor for inner heart research
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • National Institutes of Health engage Imricor for inner heart research
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • National Institutes of Health engage Imricor for inner heart research
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • National Institutes of Health engage Imricor for inner heart research
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • National Institutes of Health engage Imricor for inner heart research
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    • News

  • BTC Health drives earnings with product diversification to all major hospital operators
    BTC Health drives earnings with product diversification to all major hospital operators
    • News

  • SDI reports profit upgrade with cost cutting measure proving effective
    SDI reports profit upgrade with cost cutting measure proving effective
    • News

  • Pacific Smiles overcoming cost-of-living pressures but finally concedes a drop in dentist appointments amid takeover
    Pacific Smiles overcoming cost-of-living pressures but finally concedes a drop in dentist appointments amid takeover
    • News

  • Vita Life Sciences reports sales growth of $4m as it launches in Vietnam
    Vita Life Sciences reports sales growth of $4m as it launches in Vietnam
    • News

  • National Institutes of Health engage Imricor for inner heart research
    • News

    National Institutes of Health engage Imricor for inner heart research

    Medtech company Imricor (ASX: IMR) has been awarded a contract from the US National Institutes of Health (NIH) to advance their leading MRI technology into a prototype device that can biopsy the inner walls of the heart.  The awarded contract will see Imricor receive USD $399,539 over the next 12 months for the project where

    Read More
    Public
  • CardieX partners with tech giant Mobvoi for new health smartwatch
    • News

    CardieX partners with tech giant Mobvoi for new health smartwatch

    Biotech company CardieX (ASX: CDX) has expanded on an existing partnership with Chinese tech giant Mobvoi, which is backed by Google, for the launch of a new health-focused smartwatch which will incorporate CardieX’s software and artificial intelligence.  The smartwatch will be developed in collaboration with Mobvoi to supply hardware and firmware with CardieX to then

    Read More
    Public
  • Healthia revenues surge 40% as clinic acquisition spree continues
    • News

    Healthia revenues surge 40% as clinic acquisition spree continues

    Allied healthcare provider Healthia (ASX: HLA) has reported a 40.3% increase in revenues where business has returned to pre-COVID levels, with clinics having remained open through the pandemic in order to take pressure off the public health system as per Government directives.  Alongside the jump in revenue for FY20 to $92.4m, Healthia has also reported

    Read More
    Public
  • Hydrix successfully implants heart attack warning device in four patients
    • News

    Hydrix successfully implants heart attack warning device in four patients

    Since securing the exclusive distribution rights to the AngelMed Guardian device, the only FDA approved implantable heart attack warning system, Hydrix (ASX: HYD) has now successfully implanted the device in four patients in Singapore.  Implanted over a 3-day period, patients were selected based on their previous medical history to ensure they would benefit from the

    Read More
    Public
  • Atomo’s rapid COVID-19 test approved by TGA for distribution
    • News

    Atomo’s rapid COVID-19 test approved by TGA for distribution

    Australians will soon have access to a rapid COVID-19 test where results can be obtained in just 15 minutes from a drop of blood following approval from the Therapeutic Goods Association (TGA) for Atomo Diagnostics’ (ASX: AT1) rapid antibody test. The test device has been independently tested at laboratories in France where the AtomoRapid test

    Read More
    Public
  • Healthia secures Queensland Rugby naming rights till end of 2021
    • News

    Healthia secures Queensland Rugby naming rights till end of 2021

    Allied healthcare provider Healthia (ASX: HLA) has strengthened its position as the leading physiotherapy and podiatry provider in Queensland having secured the naming rights for State’s top club rugby competition until the end of 2021. The Allsports Physiotherapy Hospital Challenge Cup resumed at the start of August following a COVID-19 hiatus and continues Healthia’s long

    Read More
    Public
  • «
  • ‹
  • 10
  • 11
  • 12
  • 13
  • 14
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.